Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Res Sq ; 2023 May 15.
Article in English | MEDLINE | ID: mdl-37292678

ABSTRACT

The ancestral gamete fusion protein, HAP2, catalyzes sperm-egg fusion in a broad range of taxa dating to the last eukaryotic common ancestor. Remarkably, HAP2 orthologs are structurally related to the class II fusogens of modern-day viruses, and recent studies make clear that these proteins utilize similar mechanisms to achieve membrane merger. To identify factors that may regulate HAP2 activity, we screened mutants of the ciliate Tetrahymena thermophila for behaviors that mimic Δhap2 knockout phenotypes in this species. Using this approach, we identified two new genes, GFU1 and GFU2, whose products are necessary for the formation of membrane pores during fertilization and show that the product of a third gene, namely ZFR1, may be involved in pore maintenance and/or expansion. Finally, we propose a model that explains cooperativity between the fusion machinery on apposed membranes of mating cells and accounts for successful fertilization in T. thermophila's multiple mating type system.

3.
J Pediatr Gastroenterol Nutr ; 41(5): 625-33, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16254521

ABSTRACT

OBJECTIVES: To assess the safety of a polyethylene glycol (PEG) 4000 laxative without additional salts in pediatric patients. STUDY DESIGN: This was a 3-month multicenter, randomized, double-blind, double-dummy, lactulose-controlled, parallel study enrolling 96 ambulatory constipated children aged 6 months to 3 years, treated daily with 4-8 g PEG or 3.33 g-6.66 g lactulose. Total protein, albumin, iron, electrolytes, and vitamins B9 (folates), A and D (25OHD3) were measured in blood before and after treatment (day 84) in a central laboratory. RESULTS: The percentage of children with at least one value out of normal range at day 84 with respect to baseline status (with or without at least one value out of normal range), i.e. the primary endpoint, was 87% and 90% in the PEG and lactulose groups, respectively, without any difference between groups. The whole blood parameters showed no qualitative or quantitative treatment-related changes. Vitamin A values were above normal range in 56% and 41% of children at baseline versus 33% and 36% at day 84 in the PEG and lactulose groups, respectively. Iron values were similarly under normal range in 47% and 51% at baseline versus 42% and 51% at day 84. Clinical tolerance was similar for both treatments except for vomiting and flatulence, which were significantly higher with lactulose. Significantly higher improvements were evidenced with PEG regarding stool consistency, appetite, fecaloma and use of additional laxatives. CONCLUSION: This 3-month study in 96 constipated children aged 6 months to 3 years confirms the long-term tolerance of PEG 4000 in pediatrics and indicates a PEG efficacy similar to or greater than that of lactulose.


Subject(s)
Cathartics , Constipation/drug therapy , Consumer Product Safety , Lactulose , Polyethylene Glycols , Cathartics/adverse effects , Cathartics/therapeutic use , Child, Preschool , Constipation/blood , Defecation/drug effects , Digestion/drug effects , Double-Blind Method , Electrolytes/blood , Female , Flatulence/chemically induced , Gastrointestinal Agents/adverse effects , Gastrointestinal Agents/therapeutic use , Humans , Infant , Intestinal Absorption/drug effects , Lactulose/adverse effects , Lactulose/therapeutic use , Male , Polyethylene Glycols/adverse effects , Polyethylene Glycols/therapeutic use , Safety , Treatment Outcome , Vitamins/blood , Vomiting/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...